文献速递眼底病与葡萄膜炎

内源性真菌性眼内炎的治疗策略:多机构回顾性队列研究

Management strategies in endogenous fungal endophthalmitis: a multi-institutional retrospective cohort study.
PubMed 文献 · Br J Ophthalmol · 2026-09-08

该多机构回顾性队列研究纳入美国八家学术机构2010至2025年间临床或培养确诊的内源性真菌性眼内炎患者共87例118眼,描述其治疗策略与临床结局。多数患者初始接受静脉全身抗真菌治疗(64%),最常见初始药物为伏立康唑(34%)和氟康唑(30%)。静脉治疗组接受手术的比例低于口服组(21% vs 50%,p=0.001),但控制混杂因素后差异未达统计学显著(OR 0.33,95%CI 0.1至1.06,p=0.067)。

要点

  • 多数内源性真菌性眼内炎患者初始采用静脉全身抗真菌治疗,伏立康唑与氟康唑最常用。
  • 有全身症状、全身培养阳性或眼内液培养阴性的患眼更倾向初始静脉治疗。
  • 静脉抗真菌治疗可能降低需手术干预的几率,但控制混杂后未达统计学显著。

核心结论

  • 有全身性疾病的患者更可能初始接受静脉治疗,而眼部检查所见未显著影响初始全身治疗策略。
  • 初始静脉治疗可能降低需要手术干预的几率。

研究设计与样本

  • 美国八家学术机构开展的多机构回顾性队列研究。
  • 纳入2010至2025年间临床或培养确诊的内源性真菌性眼内炎患者,共87例118眼,按全身治疗途径分层分析。

主要发现

  • 64%的患者初始接受静脉全身抗真菌治疗。
  • 初始全身药物以伏立康唑(34%)和氟康唑(30%)最常用。
  • 有全身症状、全身培养阳性及眼内液培养阴性的患眼更可能初始接受静脉治疗。
  • 静脉治疗组手术比例为21%,口服组为50%(p=0.001)。
  • 初始视力较差(OR 1.78,p<0.001)和霉菌感染(OR 4.26,p<0.001)与最终视力较差相关。

关键数值与推荐

  • 静脉治疗与手术需求的关联在控制混杂因素后为OR 0.33(95%CI 0.1至1.06),p=0.067,未达统计学显著。
  • 眼部检查所见未显著影响初始治疗途径、手术需求或最终视力。

临床怎么用

  • 对合并全身症状或全身培养阳性的内源性真菌性眼内炎患者,可优先考虑静脉全身抗真菌治疗。
  • 初始视力差及霉菌感染提示最终视力预后较差,需加强监测与随访。

局限性

  • 本研究为回顾性队列研究,原文未报告其他局限性信息。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND/AIMS: Standardised treatment guidelines for endogenous fungal endophthalmitis (EFE) are lacking. The purpose of this study is to describe treatment strategies and clinical outcomes of eyes with EFE. METHODS: Retrospective cohort study performed at eight academic institutions across the USA. Demographic, clinical and treatment data for patients with clinically or culture-proven EFE between 2010 and 2025 were included. Patients were stratified by route of systemic therapy for analysis. RESULTS: A total of 118 eyes of 87 patients were included. Most patients were treated initially with intravenous systemic antifungal therapy (64%). Patients with systemic symptoms and systemic culture positivity and eyes with negative intraocular fluid cultures were more likely to be treated initially with intravenous systemic therapy. Voriconazole (34%) and fluconazole (30%) were the most used initial systemic agents. Eyes treated with intravenous antifungals were less likely to undergo surgery (intravenous 21% vs oral 50%, p=0.001), but this trend did not maintain statistical significance when controlling for confounders (OR 0.33 (95% CI 0.1 to 1.06), p=0.067). Worse presenting vision (OR 1.78, p<0.001) and infection with mould (OR 4.26, p<0.001) were associated with worse final vision. Ocular examination findings did not significantly affect the initial treatment route, the requirement for surgery or final vision. CONCLUSIONS: Patients with systemic disease were more likely to be treated initially with intravenous therapy, whereas ocular findings did not significantly influence initial systemic treatment strategy. Initial treatment with intravenous therapy may decrease the odds of requiring surgical intervention.

来源:Br J Ophthalmol,查看原文。版权归原作者所有。

引用

  1. Burton E, Shahid MM, Hu WF, et al. Management strategies in endogenous fungal endophthalmitis: a multi-institutional retrospective cohort study. Br J Ophthalmol. 2026. PMID: 42711096. doi:10.1136/bjo-2025-329157

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。